Alpha Sarcin, a New Antitumor Agent: II. Fermentation and Antitumor Spectrum

AUTOR(ES)

Olson, B. H.

RESUMO

Aspergillus giganteus MDH 18894 was found to produce alpha sarcin, a new antitumor agent inhibitory to a number of different animal tumors. This culture produced culture filtrates that inhibited mouse sarcoma 180 at dilutions up to 1:32. Optimal fermentation conditions were established for shake flasks and 30-liter and 100-gal (378.5-liter) fermentors. Results from a variety of media were reported; however, the medium which yielded the most reproducible filtrates consisted of 2% corn starch, 1.5% beef extract (Difco), 2% peptone (Difco), and 0.5% sodium chloride. Purified preparations of 800 sarcoma 180 dilution units per mg were inactive against bacteria, yeasts, molds, actinomycetes, and protozoa, but were cytotoxic to several strains of mammalian cells. Alpha sarcin inhibited sarcoma 180 in mice at a dose of 62.5 μg per kg per day. A variety of other animal tumors were also inhibited by this compound.

Documentos Relacionados

• Alpha Sarcin, a New Antitumor Agent: I. Isolation, Purification, Chemical Composition, and the Identity of a New Amino Acid
• Degradation kinetics and mechanism of RH1, a new anti-tumor agent: A technical note
• Trimethoprim-rifampin, a new combination agent: efficacy in localized urinary infection and influence on microflora.
• T-8581, a new orally and parenterally active triazole antifungal agent: in vitro and in vivo evaluations.
• Localization of an aminoacridine antitumor agent in a type II topoisomerase-DNA complex.